Baldisseri Marie R MD is categorized under Hospital, Ama Approved Residency in Pittsburgh, PA .
Baldisseri Marie R MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospital, Ama Approved Residency business, which does work in the B2C market, and is classified as a Hospital, Ama Approved Residency, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Marie Baldisseri at the company’s single location by writing to 300 Halket St, Pittsburgh, Pennsylvania PA 15213 or by phoning (412) 647-3136. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Baldisseri Marie R MD |
| Contact Person: | Marie Baldisseri |
| Address: | 300 Halket St, Pittsburgh, Pennsylvania 15213 |
| Phone Number: | (412) 647-3136 |
| Website Address: | magee.upmc.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospital, Ama Approved Residency |
| SIC Code: | 8062 |
| NAICS Code: | 6211110 |
| Share This Business: |
Baldisseri Marie R MD was started in 0 to provide professional Hospital, Ama Approved Residency under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Marie Baldisseri for inquiries that concern Baldisseri Marie R MD by calling the company number (412) 647-3136, as your correspondence is most welcome. Additionally, the physical location of the single location of Baldisseri Marie R MD can be found at the coordinates 40.43701,-79.95955 as well as the street address 300 Halket St in Pittsburgh, Pennsylvania 15213.
For its online presence, you may visit Baldisseri Marie R MD’s website at magee.upmc.com and engage with its social media outlets through on Twitter and on Facebook.